readthroughSign in
CompanyNKTXNasdaqSouth San Francisco, CA

Nkarta, Inc.

Nkarta develops allogeneic, off-the-shelf natural killer cell therapies for autoimmune diseases.

424B3Nov 12Latest SEC filing
Nov 6Latest story